Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-16
2011-08-16
Morris, Patricia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S278400
Reexamination Certificate
active
07998985
ABSTRACT:
Compound and pharmaceutical compositions comprising the compounds of the Formulaor a pharmaceutically acceptable salt thereof, as a CB1receptor inverse agonist, useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.
REFERENCES:
patent: WO 2005/077911 (2005-08-01), None
patent: WO 2005/080345 (2005-09-01), None
patent: WO 2007/020502 (2007-02-01), None
Piomelli, et al., “Review—The endocannabinoid system as a target for therapeutic drugs”,TIPS—vol. 21-218-224 (2000).
Goya, et al., “Recent advances in cannabinoid receptor agonists and antagonists”Exp. Opin. Ther. Patentsvol. 10 (10), 1529-1538 (2000).
Xiang, et al., “Pharamacology of Cannabinoid Receptor Agonists and Antagonists”.Annual Report in Medicinal Chemistry—Academic Press, NY—vol. 34. 199-208.
Francis Barth, “Cannabinoid receptor agonists and antagonists”,Expert Opinion on Therapeutic Patents—vol. 8(3) 301-313 (1998).
Andreichikov, et al. “Five membered 2,3-dioxo heterocycles, I. Synthesis and structure of 1,5-d”,Zhurnal Organicheskoi Khimii—22(10) 2208-13 (1986).
Eli Lilly and Company
Morris Patricia
Tucker R. Craig
LandOfFree
1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2647250